Showing results (21-30 of 164) with videos related to
Sort By:
Pageof 17
The British Journal of Dermatology|October 27, 2015
A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinomaM Venturini, G Gualdi, A Zanca, et al.Pancreas|April 20, 2012
Pancreatic tumor sensitivity to plasma L-asparagine starvationEmmanuelle Dufour, Fabien Gay, Karine Aguera, et al.Analytical Chemistry|September 10, 2013
Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell linesLeslie P Silva, Philip L Lorenzi, Preeti Purwaha, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 19, 2024
Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhageBosco Seong Kyu Yang, Spiros L Blackburn, Philip L Lorenzi, et al.Molecular Pharmaceutics|April 5, 2005
Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transportXueqin Song, Philip L Lorenzi, Christopher P Landowski, et al.Journal of Medicinal Chemistry|February 18, 2005
Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporterXueqin Song, Balvinder S Vig, Philip L Lorenzi, et al.ACS Nano|January 11, 2024
Intratumoral Biosynthesis of Gold Nanoclusters by Pancreatic Cancer to Overcome Delivery Barriers to RadiosensitizationAaron S Schwartz-Duval, Yuri Mackeyev, Iqbal Mahmud, et al.Farmaco (Societa Chimica Italiana : 1989)|March 1, 1996
Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivativesG Cascio, L Lorenzi, D Caglio, et al.Molecular Carcinogenesis|June 7, 2018
EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesisNirmalya Sen, Allison M Cross, Philip L Lorenzi, et al.Molecular Cancer Therapeutics|February 13, 2023
Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular CarcinomaDaoyan Wei, Dongmei Chen, Hongyuan Mou, et al.Pageof 17